Stay updated on Biogen Press Releases
Sign up to get notified when there's something new on the Biogen Press Releases page.

Latest updates to the Biogen Press Releases page
- Check2 days agoChange DetectedAdds two new press releases to the News page (March 20, 2026: Real-World, Long-Term Treatment Persistence with LEQEMBI presented at AD/PD 2026; March 19, 2026: Litifilimab Phase 2 AMETHYST data at AAD 2026). Removes two February 2026 items (Biogen Reports Fourth Quarter and Full Year 2025 Results; Nature Medicine Publishes DEVOTE SMA study results).SummaryDifference5%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedFour new news items dated March 4, 5, 10, and 11, 2026 were added; four older items dated January 7-28, 2026 were removed.SummaryDifference5%

- Check23 days agoChange DetectedAdded two new news items about Biogen's conference participation (Leerink Global Healthcare Conference 2026 and TD Cowen 46th Annual Health Care Conference). Removed two older press releases (January 6, 2026 and January 5, 2026).SummaryDifference6%

- Check38 days agoChange DetectedA new press release titled 'Biogen Announces Board Chair Transition' dated February 11, 2026 has been added to the News section.SummaryDifference0.7%

- Check45 days agoChange DetectedThree new News releases were added: Nature Medicine publishes the DEVOTE nusinersen SMA results (Feb 4, 2026); Biogen Reports Fourth Quarter and Full Year 2025 Results (Feb 6, 2026); and LEQEMBI subcutaneous formulation designated for priority review in China (Feb 8, 2026).SummaryDifference2%

- Check52 days agoChange DetectedA new Biogen news item appears on the page: 'Biogen’s Litifilimab Receives FDA Breakthrough Therapy Designation for Cutaneous Lupus Erythematosus, a Disease With No Targeted Treatment Options' dated January 28, 2026.SummaryDifference0.8%

Stay in the know with updates to Biogen Press Releases
Enter your email address, and we'll notify you when there's something new on the Biogen Press Releases page.